-
1 Comment
Tianda Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 22.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Tianda Pharmaceuticals Limited's total revenue sank by 6.7% to $123M since the same quarter in the previous year.
Its net income has increased by 18.3% to $786K since the same quarter in the previous year.
Finally, its free cash flow fell by 744.5% to $-31M since the same quarter in the previous year.
Based on the above factors, Tianda Pharmaceuticals Limited gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers-Specialty & Generic |
ISIN | KYG887471038 |
CurrencyCode | HKD |
Exchange | HK |
Beta | 0.11 |
---|---|
Dividend Yield | 1.0% |
Market Cap | 495M |
PE Ratio | None |
Target Price | None |
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0455.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024